(Nasdaq: EXEL) today announced results from a subgroup analysis of the CABINET phase 3 pivotal trial evaluating CABOMETYX ® (cabozantinib) versus placebo in patients with previously treated advanced ...

We initiated eight new positions in the quarter, highlighted by the addition of two leading biotechnology companies and ...

NVIDIA, Roche, and Lam Research lead this week's top Zacks research picks, while Tredegar and Kewaunee Scientific highlight ...

NVIDIA, Roche, and Lam Research lead today's top Zacks reports, showcasing standout growth drivers and sector-specific strengths.

You don’t have to be a CEO, baby, to be in our show. The executives are great, but Arkansas Money & Politics readers ...

Bitcoin's MVRV bands indicate that the coin remains in a mid-cycle growth phase. $3.2 billion stablecoin inflows hint at ...

Following a costly first-quarter fumble from redshirt senior tight end Lake McRee and an improvement in Wolverine freshman ...

Owens Corning is facing margin pressure, weak sales volumes, challenging end markets, and its valuations aren't necessarily ...

Bitcoin Cash price rebounds above $540 after the weekend crash. Active addresses surge to 7.28 million, reflecting a rise in ...